Mohammad Tabrizifard

Title: The Innovations of Mohammad Tabrizifard

Introduction

Mohammad Tabrizifard is a notable inventor based in Palo Alto, CA (US). He has made significant contributions to the field of biomedical research, particularly in the area of anti-coagulation therapies. With a total of 4 patents to his name, Tabrizifard's work has the potential to impact medical treatments significantly.

Latest Patents

Among his latest patents are innovative anti-coagulation factor XI antibodies. These antibodies bind to the apple 3 domain of human coagulation Factor XI, inhibiting its activation by coagulation factor XIIa. Additionally, they prevent the activation of FIX by FXIa, showcasing Tabrizifard's commitment to advancing medical science.

Career Highlights

Throughout his career, Tabrizifard has worked with prominent companies such as Merck Sharp & Dohme Corporation and Adimab, LLC. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to the advancement of therapeutic solutions.

Collaborations

Some of his notable coworkers include Zhu Chen and Kenneth Ellsworth. Their collaborative efforts have further enhanced the research and development of Tabrizifard's inventions.

Conclusion

In summary, Mohammad Tabrizifard is a distinguished inventor whose work in anti-coagulation therapies is paving the way for new medical advancements. His contributions to the field are invaluable and demonstrate the importance of innovation in healthcare.